Asset Details

  • Description:
  • Flow of rituximab in early systemic sclerosis trial. aOne patient refused to have a treatment at 6 months. bTwo patients incidentally received a dose of verum methylprednisolone instead of placebo methylprednisolone together with the RTX/placebo infusion. RTX, rituximab; AE, adverse event; SAE serious adverse event.
  • License:
  • Rights Managed
  • Rights Holder:
  • BMJ
  • License Rights Holder:
  • © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
  • Asset Type:
  • Image
  • Asset Subtype:
  • Figure
  • Image Orientation:
  • Landscape
  • Image Dimensions:
  • 1280 x 745
  • Image File Size:
  • 86.2 KB
  • Creator:
  • Maaike Boonstra, Jessica Meijs, Annemarie L Dorjée, Nina Ajmone Marsan, Anne Schouffoer, Maarten K Ninaber, Koen D Quint, Femke Bonte-Mineur, Tom W J Huizinga, Hans U Scherer, Jeska K de Vries-Bouwstra
  • Credit:
  • Boonstra, M., et al., RMD Open 3(2), e000384.
  • Collection:
  • Keywords:
  • Systemic Sclerosis, B Cells, Treatment
  • Restrictions:
  • Property Release:
  • No
  • Model Release:
  • No
  • Purchasable:
  • Yes
  • Sensitive Materials:
  • No
  • Article Authors:
  • Maaike Boonstra, Jessica Meijs, Annemarie L Dorjée, Nina Ajmone Marsan, Anne Schouffoer, Maarten K Ninaber, Koen D Quint, Femke Bonte-Mineur, Tom W J Huizinga, Hans U Scherer, Jeska K de Vries-Bouwstra
  • Article Copyright Year:
  • 2017
  • Publication Volume:
  • 3
  • Publication Issue:
  • 2
  • Publication Date:
  • 07/27/2017
  • DOI:
  • https://doi.org/10.1136/rmdopen-2016-000384

Click on image to enlarge

Would you like to download this asset? Tell us more and we can generate a quote, license and downloadable file.

Add to Cart